Information:
Fel:
ID
33713
Beskrivning
Go Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01092390
Länk
https://clinicaltrials.gov/show/NCT01092390
Nyckelord
Versioner (1)
- 2018-12-20 2018-12-20 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
20 december 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes NCT01092390
Eligibility Diabetes NCT01092390
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes NCT01092390
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Diabetes Mellitus | Oral medication | Dietary control
Item
participants have a diagnosis of diabetes (either oral medication or diet controlled)
boolean
C0011849 (UMLS CUI [1])
C0175795 (UMLS CUI [2])
C0743195 (UMLS CUI [3])
C0175795 (UMLS CUI [2])
C0743195 (UMLS CUI [3])
Systolic Pressure Average | Diastolic blood pressure Average
Item
have an average systolic blood pressure (sbp) <150 and diastolic blood pressure (dbp) <90 mmhg
boolean
C0871470 (UMLS CUI [1,1])
C1510992 (UMLS CUI [1,2])
C0428883 (UMLS CUI [2,1])
C1510992 (UMLS CUI [2,2])
C1510992 (UMLS CUI [1,2])
C0428883 (UMLS CUI [2,1])
C1510992 (UMLS CUI [2,2])
Proteinuria | Urine albumin/creatinine ratio measurement | Gender | Microalbuminuria
Item
have quantified proteinuria -- urine albumin/creatinine ratio of > 17 mg/g (men) and >25 mg/g (women) (i.e. at least microalbuminuria).
boolean
C0033687 (UMLS CUI [1])
C0455271 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0730345 (UMLS CUI [4])
C0455271 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0730345 (UMLS CUI [4])
Antihypertensive Agents Dose Stable | Hypoglycemic Agents Dose Stable | Hypolipidemic Agents Dose Stable | Antidiabetics Dose Stable
Item
participants must be on stable doses of antihypertensive, hypoglycemic, and lipid lowering medications for a minimum of two months prior to randomization. participants must agree to stay on stable doses of diabetes, antihypertensive and lipid medication for the duration of the study.
boolean
C0003364 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0020616 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0086440 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0935929 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0020616 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0086440 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0935929 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Poorly controlled diabetes mellitus | Hemoglobin A1c measurement
Item
major exclusion criteria will be poorly controlled diabetes (hemoglobin a1c >9%)
boolean
C0554876 (UMLS CUI [1])
C0474680 (UMLS CUI [2])
C0474680 (UMLS CUI [2])
Insulin use
Item
use of insulin
boolean
C0240016 (UMLS CUI [1])
Fish Oil Supplements | Fish Oil Supplements Discontinue Unwilling
Item
use of fish oil supplements or are unwilling to stop fish oil supplements one month prior to randomization and refrain from the supplements during the study
boolean
C0016157 (UMLS CUI [1,1])
C0242295 (UMLS CUI [1,2])
C0016157 (UMLS CUI [2,1])
C0242295 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C0558080 (UMLS CUI [2,4])
C0242295 (UMLS CUI [1,2])
C0016157 (UMLS CUI [2,1])
C0242295 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C0558080 (UMLS CUI [2,4])
Chronic kidney disease stage | Urine protein/creatinine ratio measurement
Item
stage 4 or stage 5 ckd or a screening urine protein/creatinine ratio of >2.5.
boolean
C2074731 (UMLS CUI [1])
C1096054 (UMLS CUI [2])
C1096054 (UMLS CUI [2])